CR

Cancer Research

The Journal of Hepatocellular Carcinoma is an international, peer-reviewed, open access journal that publishes clinical, translational, and basic research on hepatocellular carcinoma, including signaling pathways, molecular tumor classification, therapies, radiology, epidemiology, surveillance, prevention, and quality of life.

Looking to publish in Cancer Research? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.

Existing customer login
Subject Oncology
Impact Factor 16.6
Quartile Q1
Open Access Type Open
ISSN 0008-5472
eISSN 1538-7445
Invitation Only No
Cost Range Publication involves a base publication fee and an additional fee for each display item; authors may apply for a waiver of the fixed publication fee if no financial support exists.

Submission Instructions

Cancer Research accepts the following article types. Click on an article type to view submission instructions.

Original Research Articles

Cover Letter Cover letter is strongly encouraged for initial submission. Cover letter must describe how any associated manuscript is related to the current submission.
Abstract Abstract is required.
Manuscript Initial submissions do not have strict length restrictions, and the methods section is excluded when calculating manuscript length. Manuscript must be arranged in the following order: title page, text and references, tables, figure legends, and figures. Manuscript must include a conflict of interest disclosure on the title page, a Data Availability subsection at the end of the Materials and Methods or Methods section titled "Data Availability," an Acknowledgments section including funding and any generative AI or other contributors, and a Code Availability Statement if custom computer code was used.
References References must be numbered in order of first mention in the text, cited in the text by number only, and list all authors if there are 6 or fewer or the first 6 authors followed by et al. if there are more than 6.
Figures & Tables For initial submission, figures and tables should be included in a single manuscript file with each figure presented in sequence adjacent to its legend, while supplementary data must be uploaded separately. Each figure must have a legend with a short title sentence and description, multi-panel figures must have labeled panels described in the legend, figure legends must include the number of technical and biological replicates, and tables must have descriptive titles and be numbered with Arabic numerals.
Reformat to Cancer Research using Livewrite Premium

Review Manuscript

Cover Letter Cover letter is strongly encouraged for initial submission.
Abstract Abstract is required.
Manuscript Initial submissions do not have strict length restrictions, and the methods section is excluded when calculating manuscript length. Manuscript must be arranged in the following order: title page, text and references, tables, figure legends, and figures. The manuscript must include a conflict of interest disclosure on the title page, a Data Availability subsection at the end of Materials and Methods, acknowledgments of funding and nonauthor contributors, and declarations of any generative AI use in the acknowledgments or other appropriate section.
References References must be numbered in the order of first mention and cited in the text by number only. List all authors when a reference has 6 or fewer authors, but for more than 6 authors list the first 6 followed by et al.
Figures & Tables For initial submission, figures and tables should be included in a single manuscript file with each figure presented in sequence adjacent to its legend, while supplementary data must be uploaded separately. Each figure must have a legend with a short title and description, multi-panel figures must have labeled panels described in the legend, and figure legends must include the number of technical and biological replicates.
Reformat to Cancer Research using Livewrite Premium

Meta-Analysis

Cover Letter Cover letter is strongly encouraged for initial submission. Cover letter must describe how any associated manuscript is related to the current submission.
Abstract Abstract is required.
Manuscript Initial submissions do not have strict length restrictions, and the methods section is excluded when calculating manuscript length. Manuscript must be arranged in the order of title page, text and references, tables, figure legends, and figures. The manuscript must include a conflict of interest disclosure statement on the title page, a Data Availability subsection at the end of the Materials and Methods or Methods section, an acknowledgment of any generative AI or editing services in the Acknowledgments section, and a declaration of any AI-produced material in an appropriate section of the manuscript.
References References must be numbered in order of first mention in the text, cited by number only, and list all authors if there are 6 or fewer or the first 6 authors followed by et al. if there are more than 6.
Figures & Tables For initial submission, figures and tables should be included in a single manuscript file with each figure presented in sequence adjacent to its legend, while supplementary data must be uploaded separately. Each table must have a descriptive title and Arabic numeral, and each figure must have a legend with a short title sentence and panel descriptions if applicable.
Reformat to Cancer Research using Livewrite Premium

Systematic Reviews

Cover Letter Cover letter is strongly encouraged for initial submission. Cover letter must describe how any associated manuscript is related to the current submission.
Abstract Abstract is required.
Manuscript Initial submissions do not have strict length restrictions, and the methods section is excluded when calculating manuscript length. Manuscript must be arranged in the following order: title page, text and references, tables, figure legends, and figures. Manuscript must include a conflict-of-interest disclosure statement on the title page, a Data Availability subsection at the end of the Materials and Methods, and a declaration of any generative artificial intelligence or human-assisted editing contribution in the acknowledgments or other appropriate section.
References References must be numbered in order of first mention in the text, cited by number only, and list all authors for references with 6 or fewer authors or the first 6 authors followed by et al. for references with more than 6 authors.
Figures & Tables For initial submission, figures and tables should be included in a single manuscript file with each figure presented in sequential order adjacent to its legend, while supplementary data must be uploaded separately. Each table must have a descriptive title and Arabic numeral, and each figure must be cited in order and accompanied by a legend that identifies all panels, symbols, and replicate numbers.
Reformat to Cancer Research using Livewrite Premium

Recent Publications

YAP1-Driven PLCβ1 Impairs MHC-I Antigen Presentation and Limits Anti-Tumor Immunity in Gastrointestinal Cancer

Yingjing Zhang, Pengfei Su, Tian Yu, Bowen Hou, Jianpeng Gao, Fenglin Liu, Yakai Huang

10.1158/0008-5472.can-26-0635
View Publication

Exercise modulates microbial metabolites and induces stromal remodeling in pancreatic cancer

Sumedha Pareek, Robin D. Wright, Riccardo Ballarò, Cayla Xue, Thais F. Bartelli, Vidhi Chandra, Le Li, Justina Ortiz, Truong Lam, Hetal Patel, Jonghae Lee, Pradeep Shrestha, Hannah Savage, Olivereen Le Roux, Haoyue Liu, Tamara Vallejo-Schmidt, Ryan De Maleki, Vasanta Putluri, Nagireddy Putluri, Joseph F. Petrosino, Jared K. Burks, Javier A. Gomez, Jlenia Guarnerio, Matthew H. G. Katz, An Ngo-Huang, Laura R. Prakash, Nathan H. Parker, Maria Q.B. Petzel, Lin Tan, Seyda Baydogan, Florencia McAllister, Keri L. Schadler

10.1158/0008-5472.can-25-5143
View Publication

Mathematical and Mouse Models Identify Regulatory T Cell Influx as A Key Determinant of Acquired Resistance to PD-1 Immunotherapy

Rachel S. Sousa, Shannon N. Geels, Claire Murat, Alexander Moshensky, Mauro Di Pilato, S Armando Villalta, John S. Lowengrub, Francesco Marangoni

10.1158/0008-5472.can-25-5784
View Publication

The Multimodal Pretraining Framework CarHE Predicts Spatial Transcriptomics in Tumors from Routine Pathology Images

Jiawei Zou, Kai Xiao, Zexi Chen, Jiazheng Pei, Jing Xu, Tao Chen, Likun Hou, Chunyan Wu, Yunlang She, Zhiyuan Yuan, Luonan Chen

10.1158/0008-5472.can-26-1480
View Publication

Retraction: CYP3A5 Functions as a Tumor Suppressor in Hepatocellular Carcinoma by Regulating mTORC2/Akt Signaling

Feng Jiang, Lei Chen, Ying-Cheng Yang, Xian-ming Wang, Ruo-Yu Wang, Liang Li, Wen Wen, Yan-Xin Chang, Cai-Yang Chen, Jing Tang, Gao-Mi-Yang Liu, Wen-Tao Huang, Lin Xu, Hong-Yang Wang

10.1158/0008-5472.can-26-2191
View Publication

Frequently asked questions

How long does it take to publish?

Is a cover letter required?

A cover letter is strongly encouraged for initial submission.

Reformat to Cancer Research using Livewrite Premium

What are the publication costs?

Publication involves a base publication fee and an additional fee for each display item. Authors may apply for a waiver of the fixed publication fee if no financial support exists.

Reformat to Cancer Research using Livewrite Premium

Research Topics

Cancer Genomics and Diagnostics Cancer, Hypoxia, and Metabolism RNA modifications and cancer Cancer Research and Treatments Cancer Immunotherapy and Biomarkers Cancer Cells and Metastasis Cancer-related Molecular Pathways Advanced Breast Cancer Therapies Cancer-related molecular mechanisms research Breast Cancer Treatment Studies Epigenetics and DNA Methylation Monoclonal and Polyclonal Antibodies Research Cancer, Lipids, and Metabolism HER2/EGFR in Cancer Research Immunotherapy and Immune Responses Ferroptosis and cancer prognosis Prostate Cancer Treatment and Research CAR-T cell therapy research Cancer Treatment and Pharmacology Lung Cancer Treatments and Mutations Estrogen and related hormone effects Ubiquitin and proteasome pathways Nanoplatforms for cancer theranostics Protein Degradation and Inhibitors Molecular Biology Techniques and Applications

Related Journals

Ne
Neoplasia Elsevier BV
AR
Anticancer Research International Institute of Anticancer Research (IIAR) Conferences 1997. Athens, Greece. Abstracts
MO
Medical Oncology Springer Science+Business Media
CM
Cancer Medicine WILEY
NC
Nature Cancer NATURE PORTFOLIO
AJ
American Journal of Cancer Research e-Century Publishing Corporation